ArticleJournal of hematology & oncology2024

Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies: latest update from ASH 2023 annual meeting.

Yun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.